Key result
Integrated traditional Chinese and Western medicine treatment programs for elderly patients with hypertension take advantage of both modalities and warrant future study.
An integrated approach combining Western and traditional Chinese medicine may offer a balanced treatment strategy for elderly patients with hypertension, though more rigorous clinical trials are needed.
Answers are grounded in this paper and cite their sources.
May support integrated approaches in elderly hypertension; leaves open confirmation by rigorous RCTs before practice change.
Hypertension in elderly patients is a common and frequent disease which could cause stroke, heart failure and renal dysfunction. The pathogenesis of hypertension in the elderly is different from that in the young and middle-aged people, and its clinical characteristics including frequent isolated systolic hypertension, variable blood pressure, high pulse pressure, multiple complications, serious target organ damage, and so on. High prevalence, disability and mortality rates and low awareness, treatment and control rates are prominent phenomena in the elderly patients with hypertension, bringing many difficulties for clinical treatment. Presently, drug therapies for elderly patients mainly include Western medicine (WM), traditional Chinese medicine (TCM), and integrated traditional Chinese and Western medicine. WM therapy has superiority in lowering blood pressure intensively with clear mechanism, but has more adverse reactions. The effects of TCM therapy are multilinked, and TCM is good at reducing side effects and improving symptoms, but TCM preparation falls behind and its hypotensive effects are weak and slow. Furthermore, more multicenter, randomized, controlled and double-blinded clinical trials with large sample are needed to identify the effects of TCM therapy. Based on combination of TCM syndrome differentiation and WM disease differentiation, treatment programs of integrated traditional Chinese and Western medicine would take advantages of both TCM and WM treatment modalities, and are worthy of being studied in the future.
No takes yet. Share an insight, caveat, or question.
H. Li (2009) conducted a review in Hypertension. Integrated traditional Chinese and Western medicine was evaluated. Integrated traditional Chinese and Western medicine treatment programs for elderly patients with hypertension take advantage of both modalities and warrant future study.
Synapse has enriched 10 related papers. Consider them for comparative context: